URATE LOWERING EFFECT OF FEBUXOSTAT AMONG PATIENTS WITH ASYMPTOMATIC HYPERURICEMIA IN ADVANCED CHRONIC KIDNEY DISEASE: A CASE-SERIES

被引：0
|
作者：
Erika Bianca, Villazor-Isidro [1 ]
Christine Joy, Pega-Flores [1 ]
John Carlo, Brojan [1 ]
Paul, Santos-Estrella [2 ]
Jeanne, Bayaca [3 ]
机构：
[1] St Lukes Med Ctr, Dept Med, Quezon City, Philippines
[2] St Lukes Med Ctr, Rheumatol Sect, Quezon City, Philippines
[3] St Lukes Med Ctr, Nephrol Sect, Quezon City, Philippines
来源：
NEPHROLOGY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [41] Physicians' perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey
    Cha, Ran-hui
    Kim, Su Hyun
    Bae, Eun Hui
    Yu, Mina
    Choi, Beom Soon
    Choi, Hoon Young
    Kang, Sun Woo
    Shin, Jungho
    Han, Sang Youb
    Yang, Chul Woo
    Kang, Duk-Hee
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2019, 38 (03) : 373 - 381
  • [42] Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
    Chung T.-T.
    Yu K.-H.
    Kuo C.-F.
    Luo S.-F.
    Chiou M.-J.
    Lan W.-C.
    Chen J.-S.
    Tseng W.-Y.
    Hsieh A.-H.
    Wang L.-C.
    Arthritis Research & Therapy, 21 (1)
  • [43] Efficacy and safety of the urate-lowering agent febuxostat in chronic heart failure patients with hyperuricemia: results from the LEAF-CHF study
    Yokota, Takashi
    Kinugawa, Shintaro
    Fukushima, Arata
    Okumura, Takahiro
    Murohara, Toyoaki
    Tsutsui, Hiroyuki
    HEART AND VESSELS, 2025, 40 (02) : 111 - 122
  • [44] Efficacy and safety of febuxostat for treatment of asymptomatic hyperuricemia among kidney transplant patients: A meta-analysis of observational studies
    Chewcharat, Api
    Chang, Yuan-Ting
    Thongprayoon, Charat
    Crisafio, Anthony
    Bathini, Tarun
    Mao, Michael A.
    Cheungpasitporn, Wisit
    CLINICAL TRANSPLANTATION, 2020, 34 (04)
  • [45] Identifying and Addressing Suboptimal Urate Lowering Therapy in Gout Patients with Chronic Kidney Disease
    Eder, Lena
    Leverenz, David
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3783 - 3784
  • [46] A Meta-Analysis for Comparing the Effects of Febuxostat and Allopurinol on Kidney Function in Hyperuricemia Patients Complicated with Chronic Kidney Disease
    Wang, Yu
    Chen, Kai
    Zhou, Su-ya
    Qiao, Zi-xuan
    Bao, Xiao-rong
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023, 2023
  • [47] Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review
    Hu, Anna M.
    Brown, Jamie N.
    CLINICAL RHEUMATOLOGY, 2020, 39 (11) : 3287 - 3294
  • [48] Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review
    Anna M. Hu
    Jamie N. Brown
    Clinical Rheumatology, 2020, 39 : 3287 - 3294
  • [49] Asymptomatic hyperuricemia and cardiovascular mortality in patients with chronic kidney disease who progress to hemodialysis
    Tadej Petreski
    Robert Ekart
    Radovan Hojs
    Sebastjan Bevc
    International Urology and Nephrology, 2019, 51 : 1013 - 1018
  • [50] Asymptomatic hyperuricemia and cardiovascular mortality in patients with chronic kidney disease who progress to hemodialysis
    Petreski, Tadej
    Ekart, Robert
    Hojs, Radovan
    Bevc, Sebastjan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (06) : 1013 - 1018
12345